AAAAAA

   
Results: 1-11 |
Results: 11
IS THE REDUCED EFFICACY OF MORPHINE IN DIABETIC RATS CAUSED BY ALTERATIONS OF OPIATE RECEPTORS OR OF MORPHINE PHARMACOKINETICS
Authors: COURTEIX C BOURGET P CAUSSADE F BARDIN M COUDORE F FIALIP J ESCHALIER A
Citation: C. Courteix et al., IS THE REDUCED EFFICACY OF MORPHINE IN DIABETIC RATS CAUSED BY ALTERATIONS OF OPIATE RECEPTORS OR OF MORPHINE PHARMACOKINETICS, The Journal of pharmacology and experimental therapeutics, 285(1), 1998, pp. 63-70
IN-VITRO AND IN-VIVO EFFECTS OF UP-269-6, A NEW POTENT ORALLY-ACTIVE NONPEPTIDE ANGIOTENSIN-II RECEPTOR ANTAGONIST, ON VASCULAR SMOOTH-MUSCLE CELL-PROLIFERATION
Authors: VIRONEODDOS A DESANGLE V PROVOST D CAZES M CAUSSADE F CLOAREC A
Citation: A. Vironeoddos et al., IN-VITRO AND IN-VIVO EFFECTS OF UP-269-6, A NEW POTENT ORALLY-ACTIVE NONPEPTIDE ANGIOTENSIN-II RECEPTOR ANTAGONIST, ON VASCULAR SMOOTH-MUSCLE CELL-PROLIFERATION, British Journal of Pharmacology, 120(3), 1997, pp. 488-494
PARACETAMOL EXERTS A SPINAL ANTINOCICEPTIVE EFFECT INVOLVING AN INDIRECT INTERACTION WITH 5-HYDROXYTRYPTAMINE(3) RECEPTORS - IN-VIVO AND IN-VITRO EVIDENCE
Authors: PELISSIER T ALLOUI A CAUSSADE F DUBRAY C CLOAREC A LAVARENNE J ESCHALIER A
Citation: T. Pelissier et al., PARACETAMOL EXERTS A SPINAL ANTINOCICEPTIVE EFFECT INVOLVING AN INDIRECT INTERACTION WITH 5-HYDROXYTRYPTAMINE(3) RECEPTORS - IN-VIVO AND IN-VITRO EVIDENCE, The Journal of pharmacology and experimental therapeutics, 278(1), 1996, pp. 8-14
IN-VITRO PHARMACOLOGICAL CHARACTERIZATION OF UP-269-6, A NOVEL NONPEPTIDE ANGIOTENSIN-II RECEPTOR ANTAGONIST
Authors: CAUSSADE F VIRONEODDOS A DELCHAMBRE C CAZES M VERSIGNY A CLOAREC A
Citation: F. Caussade et al., IN-VITRO PHARMACOLOGICAL CHARACTERIZATION OF UP-269-6, A NOVEL NONPEPTIDE ANGIOTENSIN-II RECEPTOR ANTAGONIST, Fundamental and clinical pharmacology, 9(2), 1995, pp. 119-128
SYNTHESIS AND ANGIOTENSIN-II RECEPTOR ANTAGONIST ACTIVITY OF C-LINKEDPYRIMIDINE-DERIVATIVES
Authors: NICOLAI E CURE G GOYARD J KIRCHNER M TEULON JM VERSIGNY A CAZES M VIRONEODDOS A CAUSSADE F CLOAREC A
Citation: E. Nicolai et al., SYNTHESIS AND ANGIOTENSIN-II RECEPTOR ANTAGONIST ACTIVITY OF C-LINKEDPYRIMIDINE-DERIVATIVES, European journal of medicinal chemistry, 30(5), 1995, pp. 365-375
N6-SUBSTITUTED ADENOSINE RECEPTOR AGONISTS - SYNTHESIS AND PHARMACOLOGICAL ACTIVITY AS POTENT ANTINOCICEPTIVE AGENTS
Authors: GUNGOR T MALABRE P TEULON JM CAMBORDE F MEIGNEN J HERTZ F VIRONEODDOS A CAUSSADE F CLOAREC A
Citation: T. Gungor et al., N6-SUBSTITUTED ADENOSINE RECEPTOR AGONISTS - SYNTHESIS AND PHARMACOLOGICAL ACTIVITY AS POTENT ANTINOCICEPTIVE AGENTS, Journal of medicinal chemistry, 37(25), 1994, pp. 4307-4316
SYNTHESIS AND SAR STUDIES OF NOVEL TRIAZOLOPYRIMIDINE DERIVATIVES AS POTENT, ORALLY-ACTIVE ANGIOTENSIN-II RECEPTOR ANTAGONISTS
Authors: NICOLAI E CURE G GOYARD J KIRCHNER M TEULON JM VERSIGNY A CAZES M CAUSSADE F VIRONEODDOS A CLOAREC A
Citation: E. Nicolai et al., SYNTHESIS AND SAR STUDIES OF NOVEL TRIAZOLOPYRIMIDINE DERIVATIVES AS POTENT, ORALLY-ACTIVE ANGIOTENSIN-II RECEPTOR ANTAGONISTS, Journal of medicinal chemistry, 37(15), 1994, pp. 2371-2386
SYNTHESIS AND ANGIOTENSIN-II RECEPTOR ANTAGONIST ACTIVITY OF C-LINKEDPYRAZOLE DERIVATIVES
Authors: NICOLAI E CURE G GOYARD J KIRCHNER M TEULON JM VERSIGNY A CAZES M VIRONEODDOS A CAUSSADE F CLOAREC A
Citation: E. Nicolai et al., SYNTHESIS AND ANGIOTENSIN-II RECEPTOR ANTAGONIST ACTIVITY OF C-LINKEDPYRAZOLE DERIVATIVES, Chemical and Pharmaceutical Bulletin, 42(8), 1994, pp. 1617-1630
SYNTHESIS AND ACTIVITIES OF NEW ARYLSULFONAMIDO THROMBOXANE-A(2)-RECEPTOR ANTAGONISTS
Authors: SARTORI E CAMY F TEULON JM CAUSSADE F VIRONEODDOS A CLOAREC A
Citation: E. Sartori et al., SYNTHESIS AND ACTIVITIES OF NEW ARYLSULFONAMIDO THROMBOXANE-A(2)-RECEPTOR ANTAGONISTS, European journal of medicinal chemistry, 28(7-8), 1993, pp. 625-632
SYNTHESIS AND STRUCTURE-ACTIVITY-RELATIONSHIPS OF NOVEL BENZIMIDAZOLEAND IMIDAZO[4,5-B]PYRIDINE ACID-DERIVATIVES AS THROMBOXANE-A(2) RECEPTOR ANTAGONISTS
Authors: NICOLAI E GOYARD J BENCHETRIT T TEULON JM CAUSSADE F VIRONE A DELCHAMBRE C CLOAREC A
Citation: E. Nicolai et al., SYNTHESIS AND STRUCTURE-ACTIVITY-RELATIONSHIPS OF NOVEL BENZIMIDAZOLEAND IMIDAZO[4,5-B]PYRIDINE ACID-DERIVATIVES AS THROMBOXANE-A(2) RECEPTOR ANTAGONISTS, Journal of medicinal chemistry, 36(9), 1993, pp. 1175-1187
EFFECT OF TIENOXOLOL, A NEW DIURETIC BETA-BLOCKING AGENT, ON URINARY PROSTAGLANDIN EXCRETION IN THE RAT
Authors: CAUSSADE F CLOAREC A
Citation: F. Caussade et A. Cloarec, EFFECT OF TIENOXOLOL, A NEW DIURETIC BETA-BLOCKING AGENT, ON URINARY PROSTAGLANDIN EXCRETION IN THE RAT, British Journal of Pharmacology, 109(1), 1993, pp. 278-284
Risultati: 1-11 |